241 related articles for article (PubMed ID: 36897749)
1. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction.
Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM
Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749
[TBL] [Abstract][Full Text] [Related]
2. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.
Rieger AC; Bagno LL; Salerno A; Florea V; Rodriguez J; Rosado M; Turner D; Dulce RA; Takeuchi LM; Kanashiro-Takeuchi RM; Buchwald P; Wanschel ACBA; Balkan W; Schulman IH; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468654
[TBL] [Abstract][Full Text] [Related]
4. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
[TBL] [Abstract][Full Text] [Related]
5. Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model.
LaPenna KB; Li Z; Doiron JE; Sharp TE; Xia H; Moles K; Koul K; Wang JS; Polhemus DJ; Goodchild TT; Patel RB; Shah SJ; Lefer DJ
J Am Heart Assoc; 2023 Feb; 12(4):e028480. PubMed ID: 36752224
[TBL] [Abstract][Full Text] [Related]
6. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
9. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
11. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models.
van Ham WB; Kessler EL; Oerlemans MIFJ; Handoko ML; Sluijter JPG; van Veen TAB; den Ruijter HM; de Jager SCA
JACC Basic Transl Sci; 2022 Aug; 7(8):844-857. PubMed ID: 36061340
[TBL] [Abstract][Full Text] [Related]
12. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.
Verbrugge FH; Omote K; Reddy YNV; Sorimachi H; Obokata M; Borlaug BA
Eur Heart J; 2022 May; 43(20):1941-1951. PubMed ID: 35139159
[TBL] [Abstract][Full Text] [Related]
13. Cardiac reverse remodeling in a mouse model with many phenotypical features of heart failure with preserved ejection fraction: effects of modifying lifestyle.
Aidara ML; Walsh-Wilkinson É; Thibodeau SÈ; Labbé EA; Morin-Grandmont A; Gagnon G; Boudreau DK; Arsenault M; Bossé Y; Couët J
Am J Physiol Heart Circ Physiol; 2024 Apr; 326(4):H1017-H1036. PubMed ID: 38363584
[TBL] [Abstract][Full Text] [Related]
14. Endothelial Senescence Contributes to Heart Failure With Preserved Ejection Fraction in an Aging Mouse Model.
Gevaert AB; Shakeri H; Leloup AJ; Van Hove CE; De Meyer GRY; Vrints CJ; Lemmens K; Van Craenenbroeck EM
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611124
[TBL] [Abstract][Full Text] [Related]
15. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
16. Exercise training reverses cardiac aging phenotypes associated with heart failure with preserved ejection fraction in male mice.
Roh JD; Houstis N; Yu A; Chang B; Yeri A; Li H; Hobson R; Lerchenmüller C; Vujic A; Chaudhari V; Damilano F; Platt C; Zlotoff D; Lee RT; Shah R; Jerosch-Herold M; Rosenzweig A
Aging Cell; 2020 Jun; 19(6):e13159. PubMed ID: 32441410
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.
Marunouchi T; Matsumura K; Fuji E; Iwamoto A; Tanonaka K
Pharmacology; 2024; 109(1):43-51. PubMed ID: 38016432
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
[TBL] [Abstract][Full Text] [Related]
19. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
[TBL] [Abstract][Full Text] [Related]
20. Impairment of the adrenergic reserve associated with exercise intolerance in a murine model of heart failure with preserved ejection fraction.
Semmler L; Jeising T; Huettemeister J; Bathe-Peters M; Georgoula K; Roshanbin R; Sander P; Fu S; Bode D; Hohendanner F; Pieske B; Annibale P; Schiattarella GG; Oeing CU; Heinzel FR
Acta Physiol (Oxf); 2024 Apr; 240(4):e14124. PubMed ID: 38436094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
